Uterine Corpus Sarcoma
📧 Sign up to get email alerts when something new happens for Uterine Corpus Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 trial updating the use of gemcitabine and docetaxel in recurrent or persistent uterine cancer, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating pazopanib hydrochloride for recurrent or persistent uterine cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma [Phase 3]
Phase 3 trial evaluating gemcitabine hydrochloride and docetaxel with or without bevacizumab in advanced or recurrent uterine leiomyosarcoma…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 trial evaluating ixabepilone in patients with recurrent or persistent uterine cancer has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Phase 2]
A Phase 2 trial evaluating combination chemotherapy with filgrastim or pegfilgrastim in patients with recurrent or persistent cancer of the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy [Phase 2]
A phase 2 clinical trial evaluating ixabepilone for recurrent or persistent uterine leiomyosarcoma after prior chemotherapy has completed wi…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus [Phase 2]
Phase 2 trial of alisertib for recurrent or persistent uterine leiomyosarcoma completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus [Phase 2]
Phase 2 trial evaluating thalidomide for recurrent or persistent uterine carcinosarcoma shows completed status with posted results.